← Evidence map

ReviewOncoimmunology2026

Trial Watch - bispecific T cell engagers and higher-order multispecific immunotherapeutics.

Enfu Xue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41700001